Publicacions (330) Publicacions de José Palacios Calvo

filter_list

2024

  1. Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology, Vol. 26, Núm. 12, pp. 2935-2951

  2. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation

    Virchows Archiv, Vol. 485, Núm. 2, pp. 291-297

  3. Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology

    Scientific Reports, Vol. 14, Núm. 1

  4. Epigenetic Fingerprint of the SARS-CoV-2 Infection in the Lung of Lethal COVID-19

    Chest, Vol. 165, Núm. 4, pp. 820-824

  5. FIGO 2023 staging for endometrial cancer, when, if it is not now?

    European Journal of Cancer, Vol. 213

  6. Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison with Their Corresponding Primary Tumors

    American Journal of Surgical Pathology, Vol. 48, Núm. 12, pp. 1580-1587

  7. Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)

    International Journal of Gynecological Pathology, Vol. 43, Núm. 5, pp. 436-446

  8. NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins

    Nature Communications, Vol. 15, Núm. 1

  9. Pathologicalstaginginearlyendometrialcarcinoma

    Revisiones en Cancer, Vol. 38, Núm. 6, pp. 296-306

  10. Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape

    Frontiers in Immunology, Vol. 15

  11. Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade

    Endocrine Pathology, Vol. 35, Núm. 3, pp. 207-218

2022

  1. Biomarcadores en cáncer invasor de mama

    Revisiones en Cancer, Vol. 36, Núm. 4, pp. 185-196